Viewing Study NCT05672550


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-01-01 @ 6:57 AM
Study NCT ID: NCT05672550
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2023-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pediatric Kidney Transplant Recipients View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney transplantation View
None Children View
None Enoxaparin View
None Bayesian based dose View
None Anti-Xa activity View
None allograft thrombosis View